Last July, we first wrote about Pluristem Therapeutics , a bio-therapeutics company engaged in the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic, and autoimmune disorders.
http://www.freshnews.com/news/750087/athersys-short-term-catalyst-with-long-term-potential-
http://www.freshnews.com/news/750087/athersys-short-term-catalyst-with-long-term-potential-
No comments:
Post a Comment